Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

43

Revenue 2017

Perjeta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Perjeta was produced by Roche.

Roche's newer breast cancer drugs gain traction

Roche's newer breast cancer drugs gain traction Perjeta and Kadcyla boost 2014 revenues. Solid growth for Roche's breast cancer blockbuster Herceptin was backed up by big gains for two follow-up products in the last quarter for ... Roche's breast cancer franchise was particularly boosted by the

Pharma condemns Cancer Drugs Fund cuts

Pharma condemns Cancer Drugs Fund cuts Among the more contemplative companies was Roche, which escaped having newer cancer drugs such as Perjeta (pertuzumab) and Kadcyla (trastuzumab emtansine) removed from the list, although the CDF will no longer

Double trial disappointment for Roche

Double trial disappointment for Roche The regimens were Kadcyla plus Roche's Perjeta (pertuzumab), Kadcyla alone and Herceptin plus taxane chemotherapy.

Novartis' Afinitor fails frontline breast cancer trial

Novartis' Afinitor fails frontline breast cancer trial Afinitor conferred a seven-month improvement in PFS, and while this may warrant further study emerging data for other treatment regimens - such as the combination of Herceptin with Roche's Perjeta

NHS names drugs to be re-evaluated for Cancer Drugs Fund

NHS names drugs to be re-evaluated for Cancer Drugs Fund Kadcyla (trastuzumab emtansine). Breast cancer. Perjeta (pertuzumab). Breast cancer. Sanofi. Jevtana (cabazitaxel).

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics